Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 15 July 2026, 09:30 (CEST) to 15 July 2026, 13:30 (CEST)
Meeting summary - Medicine shortages SPOC working party meeting 15 July 2026
Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Advice on ‘end-of-year’ submission dates for type I variations in 2026
EMA Management Board: highlights of September 2026 meeting
Proceedings for the nomination and appointment of the next EMA Executive Director
Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
International Coalition of Medicines Regulatory Authorities (ICMRA)
Global regulators call for advancing alternatives to animal testing across the medicine lifecycle
Executive Director speech at EMA women’s health multi-stakeholder workshop